EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib
Autores:William Pao, Jennifer Doherty, Richard Wilson, Doris Kupfer, Mark Kris, Vincent Millerts, Katerina Politi, Elaine Mardis, Maureen Zakowski, Robert Heelan, Valerie Rusch, Lucinda Fulton, Inderpal Sarkaria, Bhuvanesh Singh, Harold Varmus